123 related articles for article (PubMed ID: 29465427)
1. Dihydrotestosterone and cancer risk.
Chan YX; Yeap BB
Curr Opin Endocrinol Diabetes Obes; 2018 Jun; 25(3):209-217. PubMed ID: 29465427
[TBL] [Abstract][Full Text] [Related]
2. Higher Dihydrotestosterone Is Associated with the Incidence of Lung Cancer in Older Men.
Chan YX; Alfonso H; Chubb SA; Handelsman DJ; Fegan PG; Hankey GJ; Golledge J; Flicker L; Yeap BB
Horm Cancer; 2017 Apr; 8(2):119-126. PubMed ID: 28233278
[TBL] [Abstract][Full Text] [Related]
3. Lower Circulating Androgens Are Associated with Overall Cancer Risk and Prostate Cancer Risk in Men Aged 25-84 Years from the Busselton Health Study.
Chan YX; Knuiman MW; Divitini ML; Handelsman DJ; Beilby JP; Yeap BB
Horm Cancer; 2018 Dec; 9(6):391-398. PubMed ID: 30097782
[TBL] [Abstract][Full Text] [Related]
4. In situ androgen and estrogen biosynthesis in endometrial cancer: focus on androgen actions and intratumoral production.
Ito K; Miki Y; Suzuki T; McNamara KM; Sasano H
Endocr Relat Cancer; 2016 Jul; 23(7):R323-35. PubMed ID: 27287451
[TBL] [Abstract][Full Text] [Related]
5. Advantages of total androgen blockade in the treatment of advanced prostate cancer.
Geller J; Albert J; Vik A
Semin Oncol; 1988 Apr; 15(2 Suppl 1):53-61. PubMed ID: 3285484
[TBL] [Abstract][Full Text] [Related]
6. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line.
Guillemette C; Hum DW; Bélanger A
Endocrinology; 1996 Jul; 137(7):2872-9. PubMed ID: 8770908
[TBL] [Abstract][Full Text] [Related]
7. Serum androgens: associations with prostate cancer risk and hair patterning.
Demark-Wahnefried W; Lesko SM; Conaway MR; Robertson CN; Clark RV; Lobaugh B; Mathias BJ; Strigo TS; Paulson DF
J Androl; 1997; 18(5):495-500. PubMed ID: 9349747
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
Platz EA; Giovannucci E
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
[TBL] [Abstract][Full Text] [Related]
9. Importance of the intracrine metabolism of adrenal androgens in androgen-dependent prostate cancer.
Suzuki K; Nishiyama T; Hara N; Yamana K; Takahashi K; Labrie F
Prostate Cancer Prostatic Dis; 2007; 10(3):301-6. PubMed ID: 17387321
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of the four major cancers in South Dakota.
Clarke J
S D Med; 2010; Spec No():6-14. PubMed ID: 20397486
[TBL] [Abstract][Full Text] [Related]
11. Regulation of steroid hydroxylase CYP7B1 by androgens and estrogens in prostate cancer LNCaP cells.
Tang W; Norlin M
Biochem Biophys Res Commun; 2006 Jun; 344(2):540-6. PubMed ID: 16630558
[TBL] [Abstract][Full Text] [Related]
12. Receptor isoform and ligand-specific modulation of dihydrotestosterone-induced prostate specific antigen gene expression and prostate tumor cell growth by estrogens.
Zhu YS; Cai LQ; Huang Y; Fish J; Wang L; Zhang ZK; Imperato-McGinley JL
J Androl; 2005; 26(4):500-8; discussion 509-10. PubMed ID: 15955889
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells.
Steele VE; Arnold JT; Lei H; Izmirlian G; Blackman MR
Anticancer Res; 2006; 26(5A):3205-15. PubMed ID: 17094431
[TBL] [Abstract][Full Text] [Related]
14. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.
Idan A; Griffiths KA; Harwood DT; Seibel MJ; Turner L; Conway AJ; Handelsman DJ
Ann Intern Med; 2010 Nov; 153(10):621-32. PubMed ID: 21079217
[TBL] [Abstract][Full Text] [Related]
16. Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.
Vatten LJ; Ursin G; Ross RK; Stanczyk FZ; Lobo RA; Harvei S; Jellum E
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):967-9. PubMed ID: 9367072
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cells.
Bruckheimer EM; Spurgers K; Weigel NL; Logothetis C; McDonnell TJ
J Urol; 2003 Apr; 169(4):1553-7. PubMed ID: 12629413
[TBL] [Abstract][Full Text] [Related]
18. Roles of androgens in the development, growth, and carcinogenesis of the mammary gland.
Liao DJ; Dickson RB
J Steroid Biochem Mol Biol; 2002 Feb; 80(2):175-89. PubMed ID: 11897502
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
20. Dihydrotestosterone affects the growth of hormone-unresponsive breast cancer cells: an indirect action.
Di Monaco M; Leonardi L; Gatto V; Gallo M; Brignardello E; Boccuzzi G
Anticancer Res; 1995; 15(6B):2581-4. PubMed ID: 8669827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
